Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
05/08/2013 | CN103083616A Traditional Chinese medicine for treating ovarian cyst |
05/08/2013 | CN103083612A Traditional Chinese medicinal composition for treating cancers, and its preparation method |
05/08/2013 | CN103083550A Oral liquid for preventing and treating gastric cancer and preparation method thereof |
05/08/2013 | CN103083513A Method for preparing high-purity dioscorea nipponica makino total saponin |
05/08/2013 | CN103083501A Soft capsule preparation for preventing and treating diseases of old people |
05/08/2013 | CN103083477A Anti-tumor dripping pills |
05/08/2013 | CN103083471A Cortex lycii radicis Chinese medical herb and brewing method thereof |
05/08/2013 | CN103083463A Cancer pain plaster |
05/08/2013 | CN103083388A Preparation method of fructus gleditsiae total saponins |
05/08/2013 | CN103083364A Pharmaceutical composition for treating cancer |
05/08/2013 | CN103083331A Application of solanum laciniatum ketene in preparing antitumor medicines |
05/08/2013 | CN103083330A Application of solasodine in preparing antitumor medicines |
05/08/2013 | CN103083329A Application of picriafel-terrae 1 in anti-tumor drug preparation |
05/08/2013 | CN103083326A Ulipristal acetate medicine composition |
05/08/2013 | CN103083324A Medicine and novel method used for intervening circulating tumor cell adhesion and infiltration into peripheral tissues |
05/08/2013 | CN103083316A SNS-595 And Methods Of Using The Same |
05/08/2013 | CN103083286A Toad venom lipophilic extract dry powder inhaler, as well as preparation method and application thereof |
05/08/2013 | CN103083279A Polysaccharide sulfate soft capsule |
05/08/2013 | CN103083273A Imatinib mesylate tablet cores, coated tablets, and preparation method thereof |
05/08/2013 | CN103083268A Polysaccharide sulfate dispersible tablet |
05/08/2013 | CN103083267A Polysaccharide sulfate chewable tablet |
05/08/2013 | CN103083261A Polysaccharide sulfate freeze-dried powder injection |
05/08/2013 | CN103083260A Gemcitabine hydrochloride for injection as well as preparation method thereof |
05/08/2013 | CN103083251A Application of tanshinone IIA-polyactic acid/hydroxyacetic acid microsphere to preparation of antitumor drugs |
05/08/2013 | CN103083250A Tanshinone IIA-polyactic acid/hydroxyacetic acid microsphere and preparation method thereof |
05/08/2013 | CN103083249A Method for preparing berberine chitosan drug-carrying microsphere by salting-out process |
05/08/2013 | CN103083248A Polysaccharide sulfate dry suspension |
05/08/2013 | CN103083240A Preparation of solid dispersions and oral preparations of paclitaxel and homologous compounds thereof |
05/08/2013 | CN103083239A Bufalin lipidosome, preparation method and application thereof |
05/08/2013 | CN103083237A Lipid emulsion of magnolol and preparation method thereof |
05/08/2013 | CN103083236A Fulvestrant containing oil needle preparation |
05/08/2013 | CN103083233A Pharmaceutical composition of paclitaxel compound |
05/08/2013 | CN103083231A Fulvestrant containing oil needle preparation |
05/08/2013 | CN103083224A Method for preparing dexamethasone slow-release medicine carrier |
05/08/2013 | CN102600180B Chinese medicinal active ingredient compound preparation for treating breast cancer and lung cancer and preparation method thereof |
05/08/2013 | CN102579373B Amoitone B nano crystallization preparation and preparation method thereof |
05/08/2013 | CN102552907B Application of non-surrounding displaced phthalocyanine zinc in preparing sonosensitizer |
05/08/2013 | CN102475890B Acceptor protein, and coding gene and application thereof |
05/08/2013 | CN102453079B Peptide specifically binding basic fibroblast growth factor receptor |
05/08/2013 | CN102441012B Golden mushroom saponifiable extract product with antitumor effect, preparation method and application thereof |
05/08/2013 | CN102319319B Solanum lyratum extract, and anticancer medicine comprising solanum lyratum extract |
05/08/2013 | CN102319222B Decitabine freeze-dried preparation and preparation method thereof |
05/08/2013 | CN102309457B Preparation method for nucleic acid nano-particle wrapping pharmacological active substances |
05/08/2013 | CN102304178B Preparation method and application of African clawed toad antitumor polypeptide |
05/08/2013 | CN102286071B Cyclic tetrapeptide compound and preparation method and use thereof |
05/08/2013 | CN102276722B Novel vascular endothelial growth factor humanized monoclonal antibody |
05/08/2013 | CN102258676B Composition for preventing lung cancer, and preparation method and application thereof |
05/08/2013 | CN102242070B Method for artificially culturing paecilomyces cicadae and application of culturing product thereof |
05/08/2013 | CN102241665B 4-(4,5-dimethoxycarboxyl-1,3-dithiolane-2-yl)benzoyl-L-amino acid benzyl ester as well as synthesis method and applications thereof |
05/08/2013 | CN102198243B Oviduct dredging medicament for removing blood stasis and warming meridians |
05/08/2013 | CN102120029B Preparation method of alginate microparticles capable of inducing tumor immune response |
05/08/2013 | CN102112133B Pharmaceutical uses of lanosta-8, 24-dien-3-ols |
05/08/2013 | CN102076345B Liquid composition comprising cisplatin-coordinating compound |
05/08/2013 | CN102060842B 3-(substituted xylylenimine-2-yl)-2,6-piperidine diketone polymorph and medical composition |
05/08/2013 | CN102020638B 2-indolinone derivative with protein kinase inhibition activity and histone deacetylase inhibition activity and preparation method and application thereof |
05/08/2013 | CN102008494B 20(R)-ginsenoside Rg3 medicinal water-solubility intermediate, freeze-dried powder injection and preparation method thereof |
05/08/2013 | CN101970404B Novel method for the production of sulphonylpyrroles as hdac inhibitors |
05/08/2013 | CN101959516B Methods of treating by inhibiting with quinaxoline inhibitors of PI3K-alpha |
05/08/2013 | CN101921271B Pyridine [2,3-d] pyrimidone compounds and application thereof to pharmacy |
05/08/2013 | CN101821243B Pyrimidinyl-propionic acid derivatives and their use as ppar agonists |
05/08/2013 | CN101821236B Five-membered heterocyclic compound |
05/08/2013 | CN101801955B Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
05/08/2013 | CN101801907B Compounds isolated from antrodia cinnamomea and use thereof |
05/08/2013 | CN101778851B 稠合的双环嘧啶 Fused bicyclic pyrimidine |
05/08/2013 | CN101712964B Fusion protein for inhibiting formation of osteoclast and preparation method as well as pharmaceutical composition thereof |
05/08/2013 | CN101631778B Cyclopenta [D] pyrimidines as AKT protein kinase inhibitors |
05/08/2013 | CN101621997B Pharmaceutical composition |
05/08/2013 | CN101560546B Application of Phosphatidylinositol4-kinase type II alpha PI4KIIalpha |
05/08/2013 | CN101252834B Plasma-depleted, non-red blood cell-depleted umbilical cord blood compositions and methods of use |
05/08/2013 | CN101163503B Extending time to disease progression or survival in cancer patients using her dimerization inhibitor |
05/08/2013 | CN101115766B Codon-optimized HPV16LI for salmonella vaccine strains against human papillomavirus type 16 |
05/07/2013 | US8436163 Splice-region antisense composition and method |
05/07/2013 | US8436137 Selective anticancer chimeric peptide comprising an EGF receptor-binding peptide and a cytotoxic peptide |
05/07/2013 | US8436047 Preventive or ameliorating agent for liver disease involving hepatopathy |
05/07/2013 | US8436012 Imidazopyridin-2-one derivatives |
05/07/2013 | US8436010 Treatment of solid tumors with rapamycin derivatives |
05/07/2013 | US8435992 Multiple myeloma treatments |
05/07/2013 | US8435987 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof |
05/07/2013 | US8435981 2-(heterocyclylbenzyl)pyridazinone derivatives |
05/07/2013 | US8435971 Use of 2,5-dihydroxybenzenesulfonic acid in the manufacturing of medicines, applicable to the treatment of angiodependent diseases |
05/07/2013 | US8435958 Method for producing pectin hydrolysis products |
05/07/2013 | US8435951 Treating neoplasms with neurotoxin |
05/07/2013 | US8435543 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
05/07/2013 | US8435534 Cancer immunotherapy |
05/07/2013 | CA2735267C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
05/07/2013 | CA2715662C Phenylpropanoid diglycerides for the treatment of cancer |
05/07/2013 | CA2681712C Tamibarotene capsule preparation |
05/07/2013 | CA2659664C Improved radiation therapy methods |
05/07/2013 | CA2607299C Compounds and compositions as protein kinase inhibitors |
05/07/2013 | CA2596618C Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for treating benign prostatic hyperplasia and/or prostate carcinoma |
05/07/2013 | CA2564197C Activatable particles, preparations and uses |
05/07/2013 | CA2538864C Thalidomide analogs as tnf-alpha modulators |
05/07/2013 | CA2529154C Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions |
05/07/2013 | CA2491131C Novel compounds as histone deacetylase inhibitors |
05/07/2013 | CA2467053C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
05/02/2013 | WO2013063498A1 Cd44 monoclonal antibody for the treatment of b-cell chronic lymphocytic leukemia and other hematological malignancies |
05/02/2013 | WO2013063492A1 Novel compositions and methods for treating cancer |
05/02/2013 | WO2013063482A2 Flt3 mutations associated with drug resistance in aml patients having activating mutations in flt3 |
05/02/2013 | WO2013063458A2 Inhibiting g protein coupled receptor 6 kinase polypeptides |
05/02/2013 | WO2013063417A1 Methyltransferase inhibitors for treating cancer |